China Fund (CHN) 19.19 $CHN
China Fund reports Q1 results
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 12:01PM CDT
CHN: 19.19 (+0.09)
The China Fund, Inc. Records First Quarter Results
PR Newswire - Tue Mar 17, 11:43AM CDT
The China Fund, Inc. (NYSE: CHN) today announced its financial results for the first quarter ended January 31, 2015. The Fund is a closed-end management investment company with the investment objective of long-term capital appreciation which it seeks to achieve by investing primarily in equity securities (i) of companies for which the principal securities trading market is the People's Republic of China ("China"
, (ii) of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods and services sold or produced, or have at least 50% of their assets, in China and (iii) constituting direct equity investments in companies organized in China.
CHN: 19.19 (+0.09)
Added To China Fund
South Gent - at Seeking Alpha - Wed Mar 04, 12:51PM CST
The China Fund (NYSE: CHN ) is a closed end fund that invests in companies with "significant assets, investments, production activities, trading or other business interests in China, or which derive a significant part of their revenue from...
CHN: 19.19 (+0.09)
DiaCarta, Inc Closes $8 Million Series A Round for Development and Commercialization of Precision Molecular Diagnostics
PR Newswire - Fri Jan 09, 4:50AM CST
DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.
CHN: 19.19 (+0.09)
The China Fund, Inc. Confirms Distributions
PR Newswire - Thu Dec 18, 1:29PM CST
The China Fund, Inc. confirms the amount of distributions of $3.7651 per share. The capital gain portion of the distributions is comprised of long-term capital gains of $3.4669 per share. The net investment income portion of the distribution is $0.2982 per share. As previously reported, the distributions will be payable on January 5, 2015 to shareholders of record on December 22, 2014 with an ex-dividend date of December 18, 2014.
CHN: 19.19 (+0.09)
China Fund names Richard Shore as new director and announces distributions of USD3.7651 per share
M2 - Tue Dec 09, 4:32AM CST
The board of directors of the China Fund Inc (NYSE:CHN), a closed-end management investment company, has named Richard Shore as a class I director as of 5 December 2014 and approved a capital gain and net investment income distribution, in the estimated aggregate amount of USD3.7651 per share, the company revealed on Monday.
CHN: 19.19 (+0.09)
The China Fund, Inc. Announces Appointment Of A New Director And Declares Distributions
PR Newswire - Mon Dec 08, 10:37AM CST
The Board of Directors (the "Board" of The China Fund, Inc. (NYSE: CHN) (the "Fund" appointed Richard Shore as a Class I Director of the Fund, effective December 5, 2014. Mr. Shore is a founding director of Reneo LLC (since 2014), a strategic consulting firm, and a founding partner of Gilbert LLP (since 2001), a boutique law firm.
CHN: 19.19 (+0.09)
The China Fund, Inc. Reports Third Quarter Results
PR Newswire - Fri Sep 12, 1:31PM CDT
The China Fund, Inc. (NYSE: CHN) today announced its financial results for the third quarter ended July 31, 2014. The Fund is a closed-end management investment company with the investment objective of long-term capital appreciation which it seeks to achieve by investing primarily in equity securities (i) of companies for which the principal securities trading market is the People's Republic of China ("China", (ii) of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods and services sold or produced, or have at least 50% of their assets, in China or (iii) constituting direct equity investments in companies organized in China.
CHN: 19.19 (+0.09)
Closed-End Funds Offer Solace for 'Cruel, Cruel Summer'
at The Street - Sun Jul 06, 8:00AM CDT
If there's a correction coming, growth, value and income investors can profit from closed-end funds.
JFC: 17.82 (+0.14), SPY: 210.41 (+0.91), PDI: 28.94 (-0.16), GOF: 21.07 (-0.09), CAF: 32.82 (+0.18), GCH: 10.22 (unch), GAB: 6.52 (-0.01), PJC: 55.31 (+0.89), DIA: 180.96 (+1.30), CHN: 19.19 (+0.09)
China Fund reports Q1 results
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 12:01PM CDT
CHN: 19.19 (+0.09)
The China Fund, Inc. Records First Quarter Results
PR Newswire - Tue Mar 17, 11:43AM CDT
The China Fund, Inc. (NYSE: CHN) today announced its financial results for the first quarter ended January 31, 2015. The Fund is a closed-end management investment company with the investment objective of long-term capital appreciation which it seeks to achieve by investing primarily in equity securities (i) of companies for which the principal securities trading market is the People's Republic of China ("China"
, (ii) of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods and services sold or produced, or have at least 50% of their assets, in China and (iii) constituting direct equity investments in companies organized in China. CHN: 19.19 (+0.09)
Added To China Fund
South Gent - at Seeking Alpha - Wed Mar 04, 12:51PM CST
The China Fund (NYSE: CHN ) is a closed end fund that invests in companies with "significant assets, investments, production activities, trading or other business interests in China, or which derive a significant part of their revenue from...
CHN: 19.19 (+0.09)
DiaCarta, Inc Closes $8 Million Series A Round for Development and Commercialization of Precision Molecular Diagnostics
PR Newswire - Fri Jan 09, 4:50AM CST
DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.
CHN: 19.19 (+0.09)
The China Fund, Inc. Confirms Distributions
PR Newswire - Thu Dec 18, 1:29PM CST
The China Fund, Inc. confirms the amount of distributions of $3.7651 per share. The capital gain portion of the distributions is comprised of long-term capital gains of $3.4669 per share. The net investment income portion of the distribution is $0.2982 per share. As previously reported, the distributions will be payable on January 5, 2015 to shareholders of record on December 22, 2014 with an ex-dividend date of December 18, 2014.
CHN: 19.19 (+0.09)
China Fund names Richard Shore as new director and announces distributions of USD3.7651 per share
M2 - Tue Dec 09, 4:32AM CST
The board of directors of the China Fund Inc (NYSE:CHN), a closed-end management investment company, has named Richard Shore as a class I director as of 5 December 2014 and approved a capital gain and net investment income distribution, in the estimated aggregate amount of USD3.7651 per share, the company revealed on Monday.
CHN: 19.19 (+0.09)
The China Fund, Inc. Announces Appointment Of A New Director And Declares Distributions
PR Newswire - Mon Dec 08, 10:37AM CST
The Board of Directors (the "Board"
of The China Fund, Inc. (NYSE: CHN) (the "Fund" appointed Richard Shore as a Class I Director of the Fund, effective December 5, 2014. Mr. Shore is a founding director of Reneo LLC (since 2014), a strategic consulting firm, and a founding partner of Gilbert LLP (since 2001), a boutique law firm. CHN: 19.19 (+0.09)
The China Fund, Inc. Reports Third Quarter Results
PR Newswire - Fri Sep 12, 1:31PM CDT
The China Fund, Inc. (NYSE: CHN) today announced its financial results for the third quarter ended July 31, 2014. The Fund is a closed-end management investment company with the investment objective of long-term capital appreciation which it seeks to achieve by investing primarily in equity securities (i) of companies for which the principal securities trading market is the People's Republic of China ("China"
, (ii) of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods and services sold or produced, or have at least 50% of their assets, in China or (iii) constituting direct equity investments in companies organized in China. CHN: 19.19 (+0.09)
Closed-End Funds Offer Solace for 'Cruel, Cruel Summer'
at The Street - Sun Jul 06, 8:00AM CDT
If there's a correction coming, growth, value and income investors can profit from closed-end funds.
JFC: 17.82 (+0.14), SPY: 210.41 (+0.91), PDI: 28.94 (-0.16), GOF: 21.07 (-0.09), CAF: 32.82 (+0.18), GCH: 10.22 (unch), GAB: 6.52 (-0.01), PJC: 55.31 (+0.89), DIA: 180.96 (+1.30), CHN: 19.19 (+0.09)
